Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet.
Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet.
复制标题
成纤维细胞生长因子21(FGF21)的缺乏促进了长期肥胖饮食小鼠的肝细胞癌(HCC)。
DOI:
10.1016/j.molmet.2018.03.002
复制
发表时间:
2018-07
影响因子:
8.1
通讯作者:
Maratos-Flier E
中科院分区:
文献类型:
--
作者:
Singhal G;Kumar G;Chan S;Fisher FM;Ma Y;Vardeh HG;Nasser IA;Flier JS;Maratos-Flier E
Non-alcoholic fatty liver (NAFL) associated with obesity is a major cause of liver diseases which can progress to non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Fibroblast growth factor 21 (FGF21) plays an important role in liver metabolism and is also a potential marker for NAFL. Here we aimed to test the effect of FGF21 deficiency on liver pathology in mice consuming a conventional high fat, high sucrose (HFHS) obesogenic diet for up to 52 weeks. C57BL6 WT and FGF21 KO mice were fed a conventional obesogenic diet and were evaluated at 16 and 52 weeks. Evaluation included metabolic assessment, liver pathology, and transcriptomic analysis. With consumption of HFHS diet, FGF21 deficient mice (FGF21 KO) develop excess fatty liver within 16 weeks. Hepatic pathology progresses and at 52 weeks FGF21 KO mice show significantly worse fibrosis and 78% of mice develop HCC; in contrast only 6% of WT mice develop HCC. Well differentiated hepatocellular carcinomas in FGF21 KO mice were characterized by expanded hepatic plates, loss of reticulin network, cytologic atypia, and positive immunostaining for glutamine synthetase. Microarray analysis reveals enrichment of several fibroblast growth factor signaling pathways in the tumors. In addition to attenuating inflammation and fibrosis in mice under a number of dietary challenges, we show here that FGF21 is required to limit the progression from NAFL to HCC in response to prolonged exposure to an obesogenic diet. The induction of hepatic FGF21 in response to the high fat, high sucrose obesogenic diet may play an important role in limiting progression of liver pathology from NAFL to HCC. FGF21 deficiency in the context of a standard high, fat high sucrose, obesogenic diet increases liver pathology with rapid progression to NASH. Hepatic pathology in FGF21 KO mice progresses to hepatocellular carcinoma. Microarray analysis of the tumors reveals enrichment of several fibroblast growth factor signaling pathways. Results noted here are similar to increased rates of progressive NAFLD in obese populations consuming Western style diets.
登录
查看更多内容
影响因子:
13.5
作者:
El-Serag, Hashem B.;Kanwal, Fasiha
通讯作者:
Kanwal, Fasiha
DOI:
10.1158/1078-0432.ccr-10-2847
发表时间:
2011-08-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Allen E;Walters IB;Hanahan D
通讯作者:
Hanahan D
影响因子:
8.1
作者:
Fisher FM;Kim M;Doridot L;Cunniff JC;Parker TS;Levine DM;Hellerstein MK;Hudgins LC;Maratos-Flier E;Herman MA
通讯作者:
Herman MA
影响因子:
13.5
作者:
Bedossa, P;Poynard, T
通讯作者:
Poynard, T
DOI:
10.1056/nejmoa0804525
发表时间:
2008-11-06
期刊:
The New England journal of medicine
影响因子:
--
作者:
Hoshida Y;Villanueva A;Kobayashi M;Peix J;Chiang DY;Camargo A;Gupta S;Moore J;Wrobel MJ;Lerner J;Reich M;Chan JA;Glickman JN;Ikeda K;Hashimoto M;Watanabe G;Daidone MG;Roayaie S;Schwartz M;Thung S;Salvesen HB;Gabriel S;Mazzaferro V;Bruix J;Friedman SL;Kumada H;Llovet JM;Golub TR
通讯作者:
Golub TR